Cubist Pharmaceuticals to Acquire Adolor for $190 Million

Cubist Pharmaceuticals Inc., the maker of the antibiotic Cubicin, said it will acquire Adolor Corp. for $190 million in cash to gain a constipation drug. Adolor shares rose the most in almost 11 years.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.